Literature DB >> 25999015

Structural elucidation and biological studies of a novel exopolysaccaride from Klebsiella pneumoniae PB12.

Amit K Mandal1, Ipsita K Sen2, Prasenjit Maity2, Sourav Chattopadhyay3, Ranadhir Chakraborty4, Somenath Roy3, Syed S Islam5.   

Abstract

An exopolysaccharide (KNPS) of an average molecular weight ∼1.8×10(5) Da was isolated from the culture medium of Klebsiella pneumoniae PB12. Structural characterization of KNPS was carried out using sugar and methylation analysis, Smith degradation and 1D/2D NMR experiments. Sugar analysis showed that the KNPS composed of arabinose, galactose, 3-O-methyl-galctose and glucose in a molar ratio of nearly 4:3:1:1. The proposed repeating unit of the KNPS has a backbone chain consisting of two (1→6)-galactopyranosyl residues, two (1→5)-arabinofuranosyl residues, one (1→6)-glucopyranosyl residue and one (1→3)-arabinopyranosyl residue, out of which one (1→6)-galactopyranosyl residue was branched at O-2 position with a (1→2)-linked-galactopyranosyl residue terminated with non reducing arabinofuranosyl residue and one (1→5)-arabinofuranosyl residue branched at O-3 position with non reducing end 3-O-Me-galactopyranosyl residue. KNPS was found non-toxic toward human lymphocyte up to the dosage of 100 μg/ml. KNPS enhanced malondialdehyde (MDA), reactive oxygen species (ROS), and have the potential to alter the ratio of oxidized glutathione (GSSG) and reduced glutathione (GSH) levels in the cellular system.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exopolysaccharide; Klebsiella pneumoniae PB12; NMR

Mesh:

Substances:

Year:  2015        PMID: 25999015     DOI: 10.1016/j.ijbiomac.2015.04.077

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

Review 1.  Microorganism-derived biological macromolecules for tissue engineering.

Authors:  Naser Amini; Peiman Brouki Milan; Vahid Hosseinpour Sarmadi; Bahareh Derakhshanmehr; Ahmad Hivechi; Fateme Khodaei; Masoud Hamidi; Sara Ashraf; Ghazaleh Larijani; Alireza Rezapour
Journal:  Front Med       Date:  2022-06-10       Impact factor: 9.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.